MASLD vs MetALD/ALD is often reduced to ‘alcohol or not’.

But alcohol use is not binary—and SLD is a dynamic spectrum where alcohol plays a significant role across phenotypes.

Time to rethink the simplistic divide 🧐

@aleksanderkrag.bsky.social
@natrevgastrohep.bsky.social

3️⃣ Patients, investigators & outcome assessors are masked to the predictive biomarker response during the trial.

@aleksanderkrag.bsky.social @mettelehmann.bsky.social @debbieshawcross.bsky.social
@easlnews.bsky.social
#liversky #cirrhosis

1️⃣ The predictive biomarker for human albumin treatment response will be validated in a randomised clinical trial.

2️⃣ Including patients with both high- and low-expected response to albumin allows granular insight into biomarker cut-offs & cost-effectiveness.

AlbTrial Update

🏥 70 out of 240 included

But what is AlbTrial?

AlbTrial is one of the most ambitious RCTs in the field of decompensated cirrhosis.

🔗 bmjopen.bmj.com/content/bmjo...

🧵below

Annual General Assembly in MicrobPredict #liversky #cirrhosis